HUP0204551A2 - Eljárás a pikkelysömör kezelésére - Google Patents

Eljárás a pikkelysömör kezelésére

Info

Publication number
HUP0204551A2
HUP0204551A2 HU0204551A HUP0204551A HUP0204551A2 HU P0204551 A2 HUP0204551 A2 HU P0204551A2 HU 0204551 A HU0204551 A HU 0204551A HU P0204551 A HUP0204551 A HU P0204551A HU P0204551 A2 HUP0204551 A2 HU P0204551A2
Authority
HU
Hungary
Prior art keywords
treatment
psoriasis
administered
patient
subject
Prior art date
Application number
HU0204551A
Other languages
English (en)
Inventor
Holly Read Thomasson
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of HUP0204551A2 publication Critical patent/HUP0204551A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány tárgya eljárás a pikkelysömör kezelése. A találmányszerint úgy járnak el, hogy egy ilyen kezelésre rászoruló betegnek egynorepinefrin-újrafelvétel inhibitor hatásos mennyiségét adják be. Ó
HU0204551A 2000-03-07 2001-02-20 Eljárás a pikkelysömör kezelésére HUP0204551A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18750800P 2000-03-07 2000-03-07
PCT/US2001/005260 WO2001066101A2 (en) 2000-03-07 2001-02-20 Treatment of psoriasis

Publications (1)

Publication Number Publication Date
HUP0204551A2 true HUP0204551A2 (hu) 2003-06-28

Family

ID=22689272

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0204551A HUP0204551A2 (hu) 2000-03-07 2001-02-20 Eljárás a pikkelysömör kezelésére

Country Status (19)

Country Link
US (1) US6683114B2 (hu)
EP (1) EP1267859A2 (hu)
JP (1) JP2003525899A (hu)
KR (1) KR20020081403A (hu)
CN (1) CN1407890A (hu)
AU (1) AU4529101A (hu)
BR (1) BR0108980A (hu)
CA (1) CA2400571A1 (hu)
DZ (1) DZ3282A1 (hu)
EA (1) EA200200948A1 (hu)
HR (1) HRP20020729A2 (hu)
HU (1) HUP0204551A2 (hu)
IL (1) IL150479A0 (hu)
MX (1) MXPA02008659A (hu)
NO (1) NO20024236D0 (hu)
PL (1) PL357042A1 (hu)
SK (1) SK12812002A3 (hu)
WO (1) WO2001066101A2 (hu)
ZA (1) ZA200205266B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050013853A1 (en) * 2000-11-29 2005-01-20 Irit Gil-Ad Anti-proliferative drugs
IL139975A0 (en) * 2000-11-29 2002-02-10 Univ Ramot Anti proliferative drugs
CN2559015Y (zh) * 2002-04-29 2003-07-02 谢基生 电动式双层近红外滤光型防盗摄影监控装置
US20040229849A1 (en) * 2002-09-24 2004-11-18 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
WO2004075902A1 (en) * 2003-02-28 2004-09-10 Amedis Pharmaceuticals Ltd. Use of silicon derivatives of venlafaxine for the treatment or prevention of psoriasis or panic disorder
WO2005011583A2 (en) * 2003-07-28 2005-02-10 Leslie Joe Dunaway Treatment of allergic rhinitis and asthma
US20100279990A1 (en) * 2006-06-13 2010-11-04 Ramot At Tel-Aviv University Ltd. Antiproliferative compounds, compositions and methods of use
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
PT2838510T (pt) * 2013-11-08 2016-11-23 Lilly Co Eli Solução de atomoxetina

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU183323B (en) * 1981-02-11 1984-04-28 Richter Gedeon Vegyeszet Process for producing 17,18-dihydro-apovincaminol-3-comma down comma aaove-4-comma down comma above-5-comma down comma aaove-trimethoxy-benzoate and acid additional salts thereof
CA2134038C (en) * 1994-06-16 1997-06-03 David Taiwai Wong Potentiation of drug response
US5508276A (en) * 1994-07-18 1996-04-16 Eli Lilly And Company Duloxetine enteric pellets
US5658590A (en) * 1995-01-11 1997-08-19 Eli Lilly And Company Treatment of attention-deficit/hyperactivity disorder
US6150396A (en) * 1997-03-07 2000-11-21 Eli Lilly And Company Methods of treating or preventing interstitial cystitis
US5916910A (en) * 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
ZA985765B (en) * 1997-07-02 1999-08-04 Merck & Co Inc Polymorphic form of a tachykinin receptor antagonist.
UA56257C2 (uk) * 1997-09-23 2003-05-15 Елі Ліллі Енд Компані Спосіб лікування неадекватної визивної поведінки
CN1301164A (zh) * 1998-04-09 2001-06-27 法玛西雅厄普约翰美国公司 神经病症的新疗法
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US6342533B1 (en) * 1998-12-01 2002-01-29 Sepracor, Inc. Derivatives of (−)-venlafaxine and methods of preparing and using the same
US6403645B2 (en) * 2000-03-16 2002-06-11 President And Fellows Of Harvard College Antidepressant effect of norepinephrine uptake 2 inhibitors and combined medications including them

Also Published As

Publication number Publication date
NO20024236L (no) 2002-09-05
SK12812002A3 (sk) 2003-08-05
WO2001066101A2 (en) 2001-09-13
KR20020081403A (ko) 2002-10-26
WO2001066101A3 (en) 2002-02-07
US20030045585A1 (en) 2003-03-06
DZ3282A1 (fr) 2001-09-13
HRP20020729A2 (en) 2004-02-29
ZA200205266B (en) 2003-10-01
JP2003525899A (ja) 2003-09-02
NO20024236D0 (no) 2002-09-05
EP1267859A2 (en) 2003-01-02
AU4529101A (en) 2001-09-17
CN1407890A (zh) 2003-04-02
US6683114B2 (en) 2004-01-27
MXPA02008659A (es) 2003-02-24
CA2400571A1 (en) 2001-09-13
PL357042A1 (en) 2004-07-12
BR0108980A (pt) 2003-06-03
IL150479A0 (en) 2002-12-01
EA200200948A1 (ru) 2003-02-27

Similar Documents

Publication Publication Date Title
EE200400020A (et) Asendatud oksasolidinoonid kombineeritud raviks
CY1116992T1 (el) Μεθοδος θεραπειας της σκληρυνσης κατα πλακας αναστελλοντας τη δραση της il-17
ATE443043T1 (de) Phenylcarboxamide als beta-sekretase-hemmer zur behandlung von alzheimer
DE50207442D1 (de) Behandlung der akne mit lipoxygenase inhibitoren
MY148459A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
SE0301882D0 (sv) New use I
UA83233C2 (ru) Замещенный 2-аминотетралин для лечения депрессии
ATE390928T1 (de) Zusammensetzungen zur behandlung von hauterkrankungen
HUP0204551A2 (hu) Eljárás a pikkelysömör kezelésére
FI20000635A0 (fi) COMT-inhibiittoreiden käyttö analgeettina
SE0004101D0 (sv) New use
NO20061425L (no) Kombinasjonen av en serotonin-reopptaksinbibitor og loxapin
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of ***e dependency
NZ519722A (en) Treatment of diabetic ulcers
SE0002739D0 (sv) New use
ATE536874T1 (de) Dreifache monoamin-wiederaufnahmehemmer zur behandlung von chronischen schmerzen
DK1455770T3 (da) Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser
ATE345135T1 (de) Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
ATE392212T1 (de) Verwendung eines proteasom-inhibitors zur behandlung fibrotischer erkrankungen
SE0301885D0 (sv) New use IV
NO20053247D0 (no) Anvendelse av levocetirizin ved behandling av vedvarende allergisk rhinitt.
ATE302009T1 (de) Ubichinon qn zur behandlung von migräneschmerzen
EA200600989A1 (ru) Применение габоксадола для лечения бессонницы
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12